KCT0005924招募中未知
A Prospective Randomized Clinical Trial in Bipolar Arthroplasty - Comparing Early Results Between the Direct Anterior Approach and the Posterior Approach
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 40(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •During the period from the date of approval of the IRB to December 25, 2021, patients aged 40 to 75 years of age who would be operated by the same orthopedic surgeon at our hospital were treated with an anterior approach and a posterior approach for artificial hip replacement.
排除标准
- •Patients with previous hip surgery experience (except hip arthroscopy), ASA sore IV or higher, BMI of 35 or higher, Dorr's classification C, patients who underwent artificial joint replacement in other joints, previous lower back of 2 segments or more Patients who underwent fusion surgery, patients with neurological, mental health, and musculoskeletal diseases that may affect rehabilitation after surgery, and patients who do not agree with the research method of this study are excluded.
研究者
相似试验
已完成
不适用
A Clinical Trial of Levocarnitine to Treat Autism Spectrum DisordersAutism Spectrum Disorder (ASD)Mental and Behavioural DisordersPervasive developmental disordersISRCTN54273114Autism Research Institute (USA)30
尚未招募
不适用
To compare the compliance of lung between equal I:E( inspiratory to expiratory)ratio and conventional ratio (1:2) ventilation in pediatric population.CTRI/2022/07/043733V Sangeetha
招募中
3 期
A Prospective Randomized Controlled Clinical Trial of Prophylactic Cranial Irradiation in Metastatic HER-2 positive Breast Cancer.Metastatic HERDŽ positive breast cancer patientsRisk of brain metastasisHER2 positivePCIMetastatic breast cancerTCTR20170612001Ratchadapiseksompotch research fund235
已完成
不适用
A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 casesCTRI/2020/07/026840Directorate of AYUSH Government of Madhya Pradesh30
已完成
2 期
To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19CTRI/2020/08/027224Central Council for Research in Ayurvedic Sciences New Delhi48